🇺🇸 Carbomer 980 in United States

84 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 84

Most-reported reactions

1. Rash — 16 reports (19.05%)
2. Lip Swelling — 10 reports (11.9%)
3. Nausea — 9 reports (10.71%)
4. Dizziness — 8 reports (9.52%)
5. Swelling Face — 8 reports (9.52%)
6. Vomiting — 8 reports (9.52%)
7. Abdominal Pain — 7 reports (8.33%)
8. Burning Sensation — 6 reports (7.14%)
9. Diarrhoea — 6 reports (7.14%)
10. Hyponatraemia — 6 reports (7.14%)

Source database →

Frequently asked questions

Is Carbomer 980 approved in United States?

Carbomer 980 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Carbomer 980 in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.